Skip to main content
SpringerLink
Log in

Multidrug resistance in human cancer

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Resistance to cytotoxic chemotherapy continues to be a major obstacle to more effective treatment of human cancers. A particular problem in clinical cancer chemotherapy is the phenomenon of simultaneous resistance of cancers to a variety of unrelated cytotoxic agents. Such resistance to multiple drugs is observed much more often than resistance to individual compounds. A similar experimental phenomenon has been termed multidrug resistance or MDR. Much has been learned in recent years about molecular mechanisms which can lead to MDR in cancer cells and a number of studies has been performed to evaluate the clinical relevance of such mechanisms. In particular, P-glycoprotein-associated MDR (MDR1) has received a lot of attention. This review will discuss (i) some principal aspects of drug resistance in cancer with particular emphasis on MDR1; (ii) available data on drug resistance mechanisms in brain tumors; and (iii) our current knowledge on the putative role of P-glycoprotein in the blood-brain barrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moscow JA, Cowan KH: Multidrug resistance. J Natl Cancer Inst 80: 14–20, 1988

    Google Scholar 

  2. Beck WT: The cell biology of multiple drug resistance. Biochem Pharmacol 36: 2870–2887, 1987

    Google Scholar 

  3. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62: 385–427, 1993

    Google Scholar 

  4. Cordon-Cardo C, O'Brien JP, Bocchia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277–1287, 1990

    Google Scholar 

  5. Chaudhary PM, Roninson IB: Expression and activity of Pglycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85–94, 1991

    Google Scholar 

  6. Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 11: 2735–2739, 1992

    Google Scholar 

  7. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695–698, 1989

    Google Scholar 

  8. Arceci RJ: Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 81: 2215–2222, 1993

    Google Scholar 

  9. Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689–704, 1990

    Google Scholar 

  10. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V: P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325: 1608–1614, 1991

    Google Scholar 

  11. Ford JM, Hait WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155–199, 1990

    Google Scholar 

  12. Sikic BI: Modulation of multidrug resistance: At the threshold. J Clin Oncol 11: 1629–1635, 1993

    Google Scholar 

  13. Lehnert M: Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues. Eur J Cancer 29A: 636–638, 1993

    Google Scholar 

  14. Lehnert M: Reversal of multidrug resistance in breast cancer: Many more open questions than answers. Ann Oncol 4: 11–13, 1993

    Google Scholar 

  15. Lehnert M: Reversal of P-glycoprotein-associated multidrug resistance: From bench to bedside. Onkologie 17: 8–15, 1994

    Google Scholar 

  16. Lum BL, Kraubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI: Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 10: 1635–1642, 1992

    Google Scholar 

  17. Levin VA, Gutin PH, Leibel S: Neoplasms of the central nervous system. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology. JB Lippincot Company, Philadelphia 1679–1737, 1993

    Google Scholar 

  18. Philips PC: Antineoplastic drug resistance in brain tumors. Neurol Clin 9: 383–404, 1991

    Google Scholar 

  19. Becker I, Becker KF, Meyermann R, Höllt V: The multidrug resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 82: 516–519, 1991

    Google Scholar 

  20. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Philips PC, Grossmann SA, Brem H, Colvin M: Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75: 941–946, 1991

    Google Scholar 

  21. Bodell WJ, Aida T, Berger MS, Rosenblum ML: Increased repair of 06-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea. Carcinogenesis 7: 879–883, 1986

    Google Scholar 

  22. Hegmann EJ, Bauer HC, Kerbel RS: Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res 52: 6969–6975, 1992

    Google Scholar 

  23. Schlosshauer B: The blood-brain barrier: Morphology, molecules, and neurothelin. BioAssays 15: 341–346, 1993

    Google Scholar 

  24. Zweit J, Carnochan P, Goodall R, Ott RJ: Excitation functions of proton induced reactions on cobalt: Production of no-carrier added Nickel-57, a positron emitting label for doxorubicin. Appl Radiat Isot 44: 1411–1416, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Laboratory, Department C of Internal Medicine, Kantonsspital, CH-9007, St. Gallen, Switzerland

    M. Lehnert

Authors
  1. M. Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehnert, M. Multidrug resistance in human cancer. J Neuro-Oncol 22, 239–243 (1994). https://doi.org/10.1007/BF01052927

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052927

Key words

Search

Navigation